Micromet(德國)

Micromet

德國Micromet www.micromet.deMicromet創(chuàng)建于德國，總部現(xiàn)設(shè)在馬里蘭州的Rockville，該公司正在開發(fā)一款試驗性血癌治療藥物，目前處在中期試驗階段。Micrometwasfoundedin1993byasmallteamofentrepreneurialscientistsfromtheUniversityofMunichwithafirmbeliefinthepo tentialofTcellbasedtherapiestotreatcancer.TheirvisionwastodevelopanewclassofdrugsthatmobilizeTcells,thebody'smostpotentkillercells,enablingthemtodetectanddestroynormallyunrecognizablecancercells.Withinafewshortyears,theCompanydemonstratedtheclinicalpotentialofitstechnology,referredtoasBiTE®(Bi-specificTcellengager),withthepublicationofcompellingresultsfromaPhase1trialofitsBiTEantibodyBlinatumomab(MT103)inpatientswithnon-Hodgkin'slymphoma.MicrometbegantradingontheNasdaqGlobalMarketunderthesymbolMITIfollowingaMay2006reversemergerwithCalifornia-basedCancerVax.TodayMicrometisanintegratedbiopharmaceuticalcompanywitha